ATE238063T1 - Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor - Google Patents

Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor

Info

Publication number
ATE238063T1
ATE238063T1 AT96945382T AT96945382T ATE238063T1 AT E238063 T1 ATE238063 T1 AT E238063T1 AT 96945382 T AT96945382 T AT 96945382T AT 96945382 T AT96945382 T AT 96945382T AT E238063 T1 ATE238063 T1 AT E238063T1
Authority
AT
Austria
Prior art keywords
growth hormone
composition containing
bovine growth
hormone releasing
releasing factor
Prior art date
Application number
AT96945382T
Other languages
English (en)
Inventor
Todd P Foster
William M Moseley
James F Caputo
Michael J Hageman
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE238063T1 publication Critical patent/ATE238063T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
AT96945382T 1996-01-11 1996-12-13 Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor ATE238063T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US973896P 1996-01-11 1996-01-11
PCT/US1996/019417 WO1997025057A1 (en) 1996-01-11 1996-12-13 Aqueous prolonged release formulation

Publications (1)

Publication Number Publication Date
ATE238063T1 true ATE238063T1 (de) 2003-05-15

Family

ID=21739423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96945382T ATE238063T1 (de) 1996-01-11 1996-12-13 Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor

Country Status (13)

Country Link
US (2) US6150330A (de)
EP (1) EP0873134B1 (de)
JP (1) JP2000506509A (de)
KR (1) KR100445087B1 (de)
CN (1) CN1130222C (de)
AT (1) ATE238063T1 (de)
CA (1) CA2240685A1 (de)
DE (1) DE69627706T2 (de)
DK (1) DK0873134T3 (de)
ES (1) ES2197258T3 (de)
NZ (1) NZ326953A (de)
PT (1) PT873134E (de)
WO (1) WO1997025057A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ326953A (en) * 1996-01-11 2001-03-30 Upjohn Co Aqueous prolonged release bovine somatotropin (bSt;BGH) formulation
WO2002062844A2 (en) * 2001-02-02 2002-08-15 Conjuchem Inc. Long lasting growth hormone releasing factor derivatives
US20060128615A1 (en) * 2002-09-18 2006-06-15 Pierrette Gaudreau Ghrh analogues
US8871713B2 (en) 2013-03-01 2014-10-28 Theratechnologies Inc. Formulations of growth hormone releasing factor (GRF) molecules with improved stability
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
US4977140A (en) * 1985-08-23 1990-12-11 Eli Lilly And Company Injectable sustained release formulation
JP2512638B2 (ja) * 1989-06-16 1996-07-03 ジ・アップジョン・カンパニー 安定化された効力のあるｇｒｆアナログ
US5756458A (en) * 1989-06-16 1998-05-26 Pharmacia & Upjohn Company Stabilized potent GRF analogs
NZ238748A (en) * 1990-06-29 1993-09-27 Hoffmann La Roche Growth hormone releasing factor (grf) analogues
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
DK0661989T3 (da) * 1992-09-21 1998-03-02 Upjohn Co Proteinsammensætninger med vedvarende frigivelse
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
NZ326953A (en) * 1996-01-11 2001-03-30 Upjohn Co Aqueous prolonged release bovine somatotropin (bSt;BGH) formulation

Also Published As

Publication number Publication date
CA2240685A1 (en) 1997-07-17
KR100445087B1 (ko) 2004-10-15
EP0873134B1 (de) 2003-04-23
DK0873134T3 (da) 2003-08-11
DE69627706D1 (de) 2003-05-28
US6429195B1 (en) 2002-08-06
AU1564997A (en) 1997-08-01
JP2000506509A (ja) 2000-05-30
CN1130222C (zh) 2003-12-10
NZ326953A (en) 2001-03-30
DE69627706T2 (de) 2004-02-05
ES2197258T3 (es) 2004-01-01
PT873134E (pt) 2003-08-29
WO1997025057A1 (en) 1997-07-17
CN1202114A (zh) 1998-12-16
US6150330A (en) 2000-11-21
HK1016083A1 (en) 1999-10-29
AU705466B2 (en) 1999-05-20
KR19990077154A (ko) 1999-10-25
EP0873134A1 (de) 1998-10-28

Similar Documents

Publication Publication Date Title
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
Taurog et al. The role of TRH in the neoteny of the Mexican axolotl (Ambystoma mexicanum)
ATE204467T1 (de) Orale darreichungsform
MY125556A (en) Aqueous formulations of peptide
DK336986D0 (da) Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner
BR8801242A (pt) Processo de preparar uma composicao para fornecer uma quantidade efetiva de uma dose constante de um ingrediente ativo a um animal e a respectiva composicao
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
RU98117135A (ru) Композиция стабилизированного гормона роста и способ ее приготовления
AR040527A1 (es) Formulaciones de hgh en alta concentracion que contienen glicina
ES2114851T3 (es) Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas.
KR870000934A (ko) 성장촉진 호르몬의 안정화 방법
ATE238063T1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor
DE69229857D1 (de) Zusammensetzung zur verwendung in der transdermalen verabreichung
GB8603964D0 (en) Compositions
DE69513635D1 (de) Wässrige zubereitung mit verzögerter wirkstofffreigabe
KR860006982A (ko) 안정한 감마 인터페론 제형의 제조방법
GR3029319T3 (en) Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
FR2684878B1 (fr) Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
WO1998029131A3 (en) Aqueous glycerol formulations of somatotropin
Brandt Jr et al. Effect of implantation and melengestrol acetate feeding on blood serum profiles and performance of heifers
TH48412A3 (th) องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0873134

Country of ref document: EP

REN Ceased due to non-payment of the annual fee